Skip to content
DilutionScan
Keros Therapeutics, Inc. logo
KROS$10.03-2.62%

Keros Therapeutics, Inc.

Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq

Mkt Cap & EV$196.83M /
Float & O/S18.78M / 19.62M
Est. Net Cash/Sh
Inst Own97.3%

DilutionScan read 50 of Keros Therapeutics, Inc.'s SEC filings and found 1 ATM program and 3 shelf registrations on file for KROS. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 16, 2026.

Signal8 Summary

DilutionScanEvery instrument in full ยท From $29.99/mo